Literature DB >> 25201189

p53: its mutations and their impact on transcription.

Catherine Vaughan1, Isabella Pearsall, Andrew Yeudall, Swati Palit Deb, Sumitra Deb.   

Abstract

p53 is a tumor suppressor protein whose key function is to maintain the integrity of the cell. Mutations in p53 have been found in up to 50 % of all human cancers and cause an increase in oncogenic phenotypes such as proliferation and tumorigenicity. Both wild-type and mutant p53 have been shown to transactivate their target genes, either through directly binding to DNA, or indirectly through protein-protein interactions. This review discusses possible mechanisms behind both wild-type and mutant p53-mediated transactivation and touches on the concept of addiction to mutant p53 of cancer cells and how that may be used for future therapies.

Entities:  

Mesh:

Year:  2014        PMID: 25201189     DOI: 10.1007/978-94-017-9211-0_4

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  20 in total

Review 1.  Transcription factors that interact with p53 and Mdm2.

Authors:  Kazushi Inoue; Elizabeth A Fry; Donna P Frazier
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

2.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

3.  Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication.

Authors:  Shilpa Singh; Catherine A Vaughan; Rebecca A Frum; Steven R Grossman; Sumitra Deb; Swati Palit Deb
Journal:  J Clin Invest       Date:  2017-04-10       Impact factor: 14.808

Review 4.  Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Int J Cancer       Date:  2016-02-08       Impact factor: 7.396

Review 5.  Polycyclic aromatic hydrocarbons and cytochrome P450 in HIV pathogenesis.

Authors:  P S S Rao; Santosh Kumar
Journal:  Front Microbiol       Date:  2015-06-02       Impact factor: 5.640

6.  Molluscs as models for translational medicine.

Authors:  Fabio Tascedda; Davide Malagoli; Alice Accorsi; Giovanna Rigillo; Johanna M C Blom; Enzo Ottaviani
Journal:  Med Sci Monit Basic Res       Date:  2015-04-30

7.  STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.

Authors:  Mao Ye; Yani Tang; Shijun Tang; Jing Liu; Kuangpei Wu; Shan Yao; Yang Sun; Lei Zhou; Tanggang Deng; Ying Chen; Chenghan Huang; Weihong Tan
Journal:  Oncotarget       Date:  2015-10-27

Review 8.  Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2.

Authors:  Toshinori Ozaki; Mizuyo Nakamura; Osamu Shimozato
Journal:  Biomolecules       Date:  2015-10-23

9.  Suppression of p53 potentiates chemosensitivity in nutrient-deprived cholangiocarcinoma cells via inhibition of autophagy.

Authors:  Fei Hu; Xian-Ling Guo; Shan-Shan Zhang; Qiu-Dong Zhao; Rong Li; Qing Xu; Li-Xin Wei
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

10.  WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway.

Authors:  Yang Sun; Lanqin Cao; Xunan Sheng; Jieying Chen; Yu Zhou; Chao Yang; Tanggang Deng; Hongchang Ma; Peifu Feng; Jing Liu; Weihong Tan; Mao Ye
Journal:  Cell Death Dis       Date:  2017-04-13       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.